Home › Calculator › CYDX Dividend Calculator 2026
CYDX Dividend DRIP Calculator 2026
170.94% YieldHealthcareCYduct Diagnostics, Inc. · OTC
Price: $1.17 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CYDX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CYDX snowball 📈
$10,000 in CYDX → $128021200142001.59M in 10 years · $10,662,342,065,763,994,000.00/month
About CYduct Diagnostics, Inc. (CYDX) — Dividend Analysis 2026
CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses. The company's extensive product offerings include specialized breast endoscopy systems, an assortment of camera solutions (such as 3-chip and 1-chip models), and all necessary accessories. They also provide a broad selection of endoscopic instruments, encompassing surgical tools like dissectors, graspers, scissors, needle holders, fan retractors, cautery devices, and insufflation needles. Furthermore, CYduct supplies illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps, alongside insufflators. For surgical specialties, their portfolio features laparoscopic instruments designed for general surgery, lymphadenectomy, gynecology, and thorascopy. Complementing these are rigid scopes (like laparoscopes, operative scopes, and cystoscopes) with their corresponding accessories, as well as trocar and cannula sets, video carts, and both insulated and non-insulated instrument handles. Uniquely, the company also provides instrumentation tailored for veterinary applications. Established in 1986, CYduct Diagnostics, Inc. is headquartered in Westport, Connecticut. The firm was formerly known as Solos Endoscopy, Inc., before adopting its current name in December 2020.
Compare CYDX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CYDX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CYDX position with:
🌍 CYDX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CYDX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 170.94% | 168.14% | $17,094 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 145.30% | 142.50% | $14,530 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 136.75% | 133.95% | $13,675 / yr |
| 🇬🇧 UK ISA | 0% | 170.94% | 168.14% | $17,094 / yr |
| 🇬🇧 UK Taxable | 8.75% | 155.98% | 153.18% | $15,598 / yr |
| 🇨🇦 TFSA | 0% | 170.94% | 168.14% | $17,094 / yr |
| 🇨🇦 CA Taxable | 25% | 128.20% | 125.40% | $12,821 / yr |
| 🇦🇺 Super (pension) | 15% | 145.30% | 142.50% | $14,530 / yr |
| 🇦🇺 AU Taxable | 30% | 119.66% | 116.86% | $11,966 / yr |
| 🇩🇪 DE Taxable | 26.375% | 125.85% | 123.05% | $12,585 / yr |
| 🇫🇷 FR Taxable | 30% | 119.66% | 116.86% | $11,966 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CYDX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CYDX Dividend Payment Schedule
CYDX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 CYDX vs Healthcare Benchmarks
How CYDX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CYDX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CYDX Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CYDX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
CYduct Diagnostics, Inc. (CYDX) is currently trading at $1.17, 44% below its 52-week high. The current dividend yield is 170.94% based on an annual payout of $2.00 per share.
CYDX (CYduct Diagnostics, Inc.) — 170.94% Dividend Yield Analysis
CYduct Diagnostics, Inc. (CYDX) is a healthcare stock currently trading at $1.17 with a dividend yield of 170.94%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (170.94%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.